- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Environmentally-Friendly
Taiwanese Pharmaceuticals & Biotech Environmentally-Friendly
UPDATED Dec 04, 2023
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
116 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 6919Caliway Biopharmaceuticals | NT$396.00 | 4.2% | n/a | NT$24.4b | n/a | PS871x | n/a | n/a | ||
| 6580TaiRx | NT$26.40 | -5.4% | -33.9% | NT$2.4b | n/a | PS376.1x | n/a | n/a | ||
| 6610TWi Biotechnology | NT$15.40 | -0.3% | 15.4% | NT$1.4b | n/a | PB8.2x | n/a | n/a | ||
| 4168GlycoNex Incorporation | NT$28.20 | -0.7% | -14.8% | NT$3.1b | n/a | PS727.9x | n/a | 0% | ||
| 6814Lukas Biomedical | NT$30.45 | 1.2% | -10.6% | NT$1.1b | n/a | PS5.3x | n/a | n/a | ||
| 6492Senhwa Biosciences | NT$55.80 | 1.5% | -15.2% | NT$5.0b | n/a | PS4976.6x | n/a | n/a | ||
| 6547Medigen Vaccine Biologics | NT$75.90 | 7.4% | -6.8% | NT$24.9b | NT$133.00 | PS103.1x | E158.5% | n/a | ||
| 6875Pharmosa Biopharm | NT$88.70 | -2.1% | 83.5% | NT$10.4b | n/a | PE190.4x | n/a | n/a | ||
| 6892Taiwan Bio Therapeutics | NT$34.10 | -0.1% | 2.6% | NT$1.7b | n/a | n/a | n/a | n/a | ||
| 6973U-Neuron Biomedical | NT$41.05 | -2.3% | n/a | NT$1.2b | n/a | n/a | n/a | n/a | ||
| 6677Anxo Pharmaceutical | NT$50.10 | -4.6% | 106.2% | NT$2.8b | n/a | PE83.8x | n/a | 0% | ||
| 4117General Biologicals | NT$28.45 | 1.2% | 18.0% | NT$1.7b | n/a | PS6.1x | n/a | n/a | ||
| 6461Intech Biopharm | NT$27.90 | 0.7% | -12.1% | NT$3.3b | n/a | PS133x | n/a | n/a | ||
| 4133Abnova (Taiwan) | NT$36.60 | -2.4% | -3.6% | NT$2.2b | n/a | PE49.6x | n/a | 2.2% | ||
| 4119SCI Pharmtech | NT$91.60 | 1.4% | 9.4% | NT$10.9b | NT$116.44 | PE29x | n/a | 0.2% | ||
| 4192SynCore BiotechnologyLtd | NT$36.80 | 0.3% | -64.2% | NT$1.3b | n/a | PS67.7x | n/a | n/a | ||
| 6848RBC Bioscience | NT$18.35 | 15.0% | 21.1% | NT$238.1m | n/a | PS1.5x | n/a | 6.1% | ||
| 6864Anti-Microbial Savior BioteQ | NT$25.70 | -1.9% | 5.3% | NT$642.5m | n/a | n/a | n/a | n/a | ||
| 6935Prince Pharmaceutical | NT$35.10 | 0.4% | n/a | NT$1.3b | n/a | PE53.3x | n/a | n/a | ||
| 6932Mercury Biopharmaceutical | NT$19.60 | -2.2% | n/a | NT$8.2b | n/a | PS3042.1x | n/a | n/a | ||
| 6794UnicoCell Biomed | NT$88.60 | 2.4% | 172.6% | NT$4.9b | n/a | PS271.3x | n/a | n/a | ||
| 6817Winston Medical SupplyLtd | NT$108.00 | 0.9% | 91.2% | NT$2.0b | n/a | PE14x | n/a | 4.6% | ||
| 8432TSH Biopharm | NT$49.90 | -1.8% | 7.9% | NT$1.9b | n/a | PE35.6x | n/a | 3.2% | ||
| 6539DV Biomed | NT$50.00 | -1.4% | -9.4% | NT$3.0b | n/a | PE11.9x | n/a | 10.0% |